1-4 of 4
secondary myelofibrosis
Close
Sort by
Journal Articles

Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis

Clinical Trials & Observations
Sebastiano Rontauroli, Sara Castellano, Paola Guglielmelli, Roberta Zini, Elisa Bianchi, Elena Genovese, Chiara Carretta, Sandra Parenti, Sebastian Fantini, Selene Mallia, Lara Tavernari, Stefano Sartini, Margherita Mirabile, Carmela Mannarelli, Francesca Gesullo, Annalisa Pacilli, Daniela Pietra, Elisa Rumi, Silvia Salmoiraghi, Barbara Mora, Laura Villani, Andrea Grilli, Vittorio Rosti, Giovanni Barosi, Francesco Passamonti, Alessandro Rambaldi, Luca Malcovati, Mario Cazzola, Silvio Bicciato, Enrico Tagliafico, Alessandro M. Vannucchi, Rossella Manfredini
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1452–1462.
https://doi.org/10.1182/bloodadvances.2020003614
Published: 2021
Includes: Supplemental data
Journal Articles

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study

Clinical Trials & Observations
Damien Luque Paz, Jérémie Riou, Emmanuelle Verger, Bruno Cassinat, Aurélie Chauveau, Jean-Christophe Ianotto, Brigitte Dupriez, Françoise Boyer, Maxime Renard, Olivier Mansier, Anne Murati, Jérôme Rey, Gabriel Etienne, Véronique Mansat-De Mas, Suzanne Tavitian, Olivier Nibourel, Stéphane Girault, Yannick Le Bris, François Girodon, Dana Ranta, Jean-Claude Chomel, Pascale Cony-Makhoul, Pierre Sujobert, Margot Robles, Raouf Ben Abdelali, Olivier Kosmider, Laurane Cottin, Lydia Roy, Ivan Sloma, Fabienne Vacheret, Mathieu Wemeau, Pascal Mossuz, Borhane Slama, Vincent Cussac, Guillaume Denis, Anouk Walter-Petrich, Barbara Burroni, Nathalie Jézéquel, Stéphane Giraudier, Eric Lippert, Gérard Socié, Jean-Jacques Kiladjian, Valérie Ugo
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1442–1451.
https://doi.org/10.1182/bloodadvances.2020003444
Published: 2021
Includes: Supplemental data
Journal Articles

Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden

Clinical Trials & Observations
Theodoros Karantanos, Shruti Chaturvedi, Evan M. Braunstein, Jerry Spivak, Linda Resar, Styliani Karanika, Donna M. Williams, Ophelia Rogers, Christopher D. Gocke, Alison R. Moliterno
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2567–2576.
https://doi.org/10.1182/bloodadvances.2019001407
Published: 2020
Includes: Supplemental data
Journal Articles

Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms

Junshik Hong, Ju Hyun Lee, Ja Min Byun, Ji Yun Lee, Youngil Koh, Dong-Yeop Shin, Jeong-Ok Lee, Sang Mee Hwang, Hyoung Soo Choi, Inho Kim, Sung-Soo Yoon, Soo-Mee Bang
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3700–3708.
https://doi.org/10.1182/bloodadvances.2019000655
Published: 2019
Includes: Supplemental data